131 related articles for article (PubMed ID: 2827907)
1. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone.
Vargish T; Beamer KC; Daly T; Riggs TR
Circ Shock; 1987; 23(3):189-95. PubMed ID: 2827907
[TBL] [Abstract][Full Text] [Related]
2. Morphine depression of myocardial function.
Riggs TR; Yano Y; Vargish T
Circ Shock; 1986; 19(1):31-8. PubMed ID: 3719915
[TBL] [Abstract][Full Text] [Related]
3. Myocardial opiate receptor activity is stereospecific, independent of muscarinic receptor antagonism, and may play a role in depressing cardiac function.
Vargish T; Beamer KC; Daly T; Head R
Surgery; 1987 Aug; 102(2):171-7. PubMed ID: 2887040
[TBL] [Abstract][Full Text] [Related]
4. Opiate agonist depression of myocardial function is dose related and independent of pentobarbital or chloral hydrate anesthesia.
Riggs TR; Yano Y; Vargish T
Am Surg; 1986 Dec; 52(12):654-8. PubMed ID: 3789544
[TBL] [Abstract][Full Text] [Related]
5. Effects of naloxone and morphine in hemorrhagic shock.
Isoyama T; Tanaka J; Sato T; Shatney CH
Circ Shock; 1982; 9(4):375-82. PubMed ID: 7116576
[TBL] [Abstract][Full Text] [Related]
6. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
7. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
Eisenberg RM
J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
9. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
[TBL] [Abstract][Full Text] [Related]
10. Microiontophoretically applied morphine and naloxone on single cell activity in the parafasciculus nucleus of naive and morphine-dependent rats.
Reyes-Vazquez C; Dafny N
J Pharmacol Exp Ther; 1984 May; 229(2):583-8. PubMed ID: 6325669
[TBL] [Abstract][Full Text] [Related]
11. Pressor effect of nalbuphine in hemorrhagic shock is dependent on the sympathoadrenal system.
Muldoon SM; McKenzie JE; Collins FJ
Circ Shock; 1988 Sep; 26(1):89-98. PubMed ID: 2847883
[TBL] [Abstract][Full Text] [Related]
12. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion.
Shi E; Jiang X; Bai H; Gu T; Chang Y; Wang J
Chin Med J (Engl); 2003 Jul; 116(7):1059-62. PubMed ID: 12890384
[TBL] [Abstract][Full Text] [Related]
14. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
Tao PL; Law PY; Loh HH
J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
[TBL] [Abstract][Full Text] [Related]
15. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
16. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
Pechnick R; George R; Poland RE
J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
[TBL] [Abstract][Full Text] [Related]
17. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
Zadina JE; Chang SL; Ge LJ; Kastin AJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
[TBL] [Abstract][Full Text] [Related]
18. The effects of opiate agonists on growth hormone and prolactin release in rats.
Shaar CJ; Clemens JA
Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
[TBL] [Abstract][Full Text] [Related]
19. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
Pasternak GW; Childers SR; Snyder SH
J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
[TBL] [Abstract][Full Text] [Related]
20. Central mu-opiate receptors and the cardiac release of atrial natriuretic factor (ANF).
Szecowka J; Campino C; Huidobro-Toro JP
Prog Clin Biol Res; 1990; 328():363-6. PubMed ID: 2154794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
